Pearce G - Search Results

1

Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy.

Inman W, Pearce G, Wilton L. Inman W, et al. Among authors: pearce g. Eur J Clin Pharmacol. 1994;46(2):115-8. doi: 10.1007/BF00199872. Eur J Clin Pharmacol. 1994. PMID: 8039528

2

Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance.

Mann RD, Wilton LV, Pearce GL, Mackay FJ, Dunn NR. Mann RD, et al. Among authors: pearce gl. Pharmacoepidemiol Drug Saf. 1997 Oct;6 Suppl 3:S5-11. doi: 10.1002/(SICI)1099-1557(199710)6:3+3.0.CO;2-F. Pharmacoepidemiol Drug Saf. 1997. PMID: 15073748 No abstract available.

3

A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies.

Mackay FJ, Dunn NR, Wilton LV, Pearce GL, Freemantle SN, Mann RD. Mackay FJ, et al. Among authors: pearce gl. Pharmacoepidemiol Drug Saf. 1997 Jul;6(4):235-46. doi: 10.1002/(SICI)1099-1557(199707)6:4<235::AID-PDS293>3.0.CO;2-3. Pharmacoepidemiol Drug Saf. 1997. PMID: 15073774

4

Nefazodone in community use: the results of prescription-event monitoring.

Mackay FJ, Pearce GL, Freemantle SN, Mann RD. Mackay FJ, et al. Among authors: pearce gl. Pharmacoepidemiol Drug Saf. 1999 Jul;8(4):267-73. doi: 10.1002/(SICI)1099-1557(199907)8:4<267::AID-PDS423>3.0.CO;2-K. Pharmacoepidemiol Drug Saf. 1999. PMID: 15073919

5

Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring.

Layton D, Pearce GL, Shakir SA. Layton D, et al. Among authors: pearce gl. Drug Saf. 2001;24(9):703-13. doi: 10.2165/00002018-200124090-00005. Drug Saf. 2001. PMID: 11522122

6

Safety of long-term lamotrigine in epilepsy.

Mackay FJ, Wilton LV, Pearce GL, Freemantle SN, Mann RD. Mackay FJ, et al. Among authors: pearce gl. Epilepsia. 1997 Aug;38(8):881-6. doi: 10.1111/j.1528-1157.1997.tb01252.x. Epilepsia. 1997. PMID: 9579888

7

United Kingdom experience with alendronate and oesophageal reactions.

Mackay FJ, Wilton LV, Pearce GL, Freemantle SN, Mann RD. Mackay FJ, et al. Among authors: pearce gl. Br J Gen Pract. 1998 Apr;48(429):1161-2. Br J Gen Pract. 1998. PMID: 9667093 Free PMC article.

8

Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies.

Martin RM, Biswas PN, Freemantle SN, Pearce GL, Mann RD. Martin RM, et al. Among authors: pearce gl. Br J Clin Pharmacol. 1998 Nov;46(5):505-11. doi: 10.1046/j.1365-2125.1998.00817.x. Br J Clin Pharmacol. 1998. PMID: 9833605 Free PMC article.

9

Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.

Clark DW, Layton D, Wilton LV, Pearce GL, Shakir SA. Clark DW, et al. Among authors: pearce gl. Drug Saf. 2001;24(15):1143-54. doi: 10.2165/00002018-200124150-00005. Drug Saf. 2001. PMID: 11772147

10

Adverse effects associated with the use of donepezil in general practice in England.

Dunn NR, Pearce GL, Shakir SA. Dunn NR, et al. Among authors: pearce gl. J Psychopharmacol. 2000;14(4):406-8. doi: 10.1177/026988110001400410. J Psychopharmacol. 2000. PMID: 11198060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results